title: Subcutaneous administration of muscarinic antagonists and triple-immunostaining of the levator auris longus muscle in mice.
abstract: Hind limb muscles of rodents, such as gastrocnemius and tibialis anterior, are frequently used for in vivo pharmacological studies of the signals essential for the formation and maintenance of mammalian NMJs. However, drug penetration into these muscles after subcutaneous or intramuscular administration is often incomplete or uneven and many NMJs can remain unaffected. Although systemic administration with devices such as mini-pumps can improve the spatiotemporal effects, the invasive nature of this approach can cause confounding inflammatory responses and/or direct muscle damage. Moreover, complete analysis of the NMJs in a hind limb muscle is challenging because it requires time-consuming serial sectioning and extensive immunostaining. The mouse LAL is a thin, flat sheet of muscle located superficially on the dorsum of the neck. It is a fast-twitch muscle that functions to move the pinna. It contains rostral and caudal portions that originate from the midline of the cranium and extend laterally to the cartilaginous portion of each pinna. The muscle is supplied by a branch of the facial nerve that projects caudally as it exits the stylomastoid foramen. We and others have found LAL to be a convenient preparation that offers advantages for the investigation of both short and long-term in vivo effects of drugs on NMJs and muscles. First, its superficial location facilitates multiple local applications of drugs under light anesthesia. Second, its thinness (2-3 layers of muscle fibers) permits visualization and analysis of almost all the NMJs within the muscle. Third, the ease of dissecting it with its nerve intact together with the pattern of its innervation permits supplementary electrophysiological analysis in vitro. Last, and perhaps most importantly, a small applied volume (-50 μl) easily covers the entire muscle surface, provides a uniform and prolonged exposure of all its NMJs to the drug and eliminates the need for a systemic approach.
authors.affiliation: Biology Department, Arcadia University.
authors.forename: Megan
authors.initials: M
authors.lastname: Wright
authors.forename: Amy
authors.initials: A
authors.lastname: Kim
authors.forename: Young-Jin
authors.initials: YJ
authors.lastname: Son
mesh_terms: D000818:Animals; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D007150:Immunohistochemistry / Q000379:methods; D051379:Mice; D018727:Muscarinic Antagonists / Q000494:pharmacology*; D018656:Muscle Fibers, Fast-Twitch / Q000187:drug effects*; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000294:innervation*; D009333:Neck; D009469:Neuromuscular Junction / Q000187:drug effects; D011976:Receptors, Muscarinic / Q000737:chemistry / Q000378:metabolism
chemical_list: D018727:Muscarinic Antagonists; D011976:Receptors, Muscarinic